Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03.01.2024 - -Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) - Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral ...
Praveen Tipirneni Chief Executive Officer Healthcare Conference Morphic Holding Chart Orphic Holding Kurs Orphic Holding Aktie
Source: wallstreet-online.de